Patent · US Active

Use of non-subtype B gag proteins for lentiviral packaging

US9752160B2 · kind B2 · utility

0Cited by

1References

13Claims

0Family size

Assignees

THERAVECTYS · FR
INSTITUT PASTEUR · FR

Inventors

Thi-Lan Tran · Vélizy-Villacoublay, FR
Pierre Charneau · Paris, FR
Cecile Bauche · Paris, FR

Key dates

Filing date	Sep 25, 2012
Grant date	Sep 5, 2017
Priority date	—
Expiry date	Sep 25, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2800/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention encompasses a lentiviral packaging vector comprising a non-subtype B gag-pol sequence, particularly a subtype D gag-pol sequence. The invention further encompasses methods for making and using these vectors. The invention further encompasses lentiviral vector particles comprising HIV-1 non-subtype B Gag and/or Pol proteins.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.